"Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"The "Psychedelics Capital Podcast" host Ross O'Brien from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscap

Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics

Jul 6th, 2023 24m 38s

Exploring the Potential of Psychedelics and Natural CompoundsDick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating ment

Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries

Mar 30th, 2023 42m 43s

Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and ps

Exploring the Future of Psychedelic Medicine: An Entrepreneur's Journey with Greg McKee

Mar 23rd, 2023 43m 50s

In this episode host Ross O'Brien from Bonaventure Equity interviews Greg McKee, the founder and CEO of Journey Life Sciences and a managing partner at Bonaventure Equity. O'Brien and McKee discuss the emerging world of psychedelics and ventur

Nick Norris

Mar 9th, 2023 53m 8s

Deep preparation, with a focus on integration and continued therapyU.S. Navy SEAL veteran, entrepreneur, and founder of Protekt Products Nick Norris joins Ross O'Brien from Bonaventure Equity to explain how psychedelic therapy helped him reign

Trailer

Feb 5th, 2023 39s

Welcome to Psychedelic Capital a show about investing in the new frontier of life sciences. Premiering March 9th, join Bonaventure Capital's CEO Ross O'Brien as he tackles some of health cares biggest challenges with key thought-leaders, inves

Rate